This FLASHcard(TM) is a 4-inch x 7-inch durable plastic card containing evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students. The Antiretroviral Agents in HIV-1 FLASHcard(TM) reflects current guidelines from the National Institutes of Health, Centers for Disease Control, including indications for treatment, baseline evaluation, recommendations, and recommended antiretroviral regimens. The Antiretroviral Agents in HIV-1 FLASHcard(TM) provides a compact summary of all that is needed to make accurate clinical decisions at the point of care including indications for initiating antiretroviral therapy; baseline laboratory evaluation; antiretroviral regimens recommended for treatment of naAve patients (preferred, alternate, acceptable). Applications include point-of-care, education, QI interventions, clinical trials, medical reference, and clinical research.